米国の滅菌器市場見通し（～2021）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Sterilization Equipment Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Sterilization Equipment Market, United States 9
3.1 Sterilization Equipment Market, United States, Revenue ($m), 2007-2014 9
3.2 Sterilization Equipment Market, United States, Revenue ($m), 2014-2021 11
3.2.1 Chemical Sterilizers Market, United States, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Chemical Sterilizers Market, United States, Revenue ($m), by Segment, 2014-2021 15
3.3 Sterilization Equipment Market, United States, Volume (Units), 2007-2014 17
3.4 Sterilization Equipment Market, United States, Volume (Units), 2014-2021 19
3.4.1 Chemical Sterilizers Market, United States, Volume (Units), by Segment, 2007-2014 21
3.4.2 Chemical Sterilizers Market, United States, Volume (Units), by Segment, 2014-2021 23
3.5 Sterilization Equipment Market, United States, Average Price ($), 2007-2021 25
3.6 Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), 2013-2014 27
3.7 Sterilization Equipment Market, United States, Company Share by Revenue ($m), 2014 28
4 Overview of Key Companies in United States, Sterilization Equipment Market 30
4.1 Steris Corporation 30
4.1.1 Company Overview 30
4.2 Advanced Sterilization Products Services Inc. 30
4.2.1 Company Overview 30
4.3 Tuttnauer USA Co. Ltd. 30
4.3.1 Company Overview 30
4.4 Getinge AB 31
4.4.1 Company Overview 31
4.5 3M Health Care Ltd. 31
4.5.1 Company Overview 31
4.6 Belimed Sauter AG 32
4.6.1 Company Overview 32
5 Sterilization Equipment Market Pipeline Products 33
6 Financial Deals Landscape 34
6.1 Acquisition 34
6.1.1 Steris to Acquire General Econopak for USD175 Million 34
6.2 Asset Transactions 36
6.2.1 Crosstex International to Acquire Sterility Assurance Products Division of North American Science Associates 36
6.2.2 Xellia Pharma Acquires Manufacturing Facilities from Hikma Pharma 38
6.2.3 Medline Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million 40
6.3 Equity Offerings 42
6.3.1 Pure Bioscience Raises USD6 Million in Private Placement of Shares 42
6.4 Private Equity 43
6.4.1 RoundTable Healthcare Acquires TIDI Products from J.H. Whitney 43
7 Recent Developments 45
7.1 Corporate Communications 45
7.1.1 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 45
7.1.2 Aug 07, 2015: Cantel Medical Appoints David Rosen as President, Asia Pacific and Emerging Markets 45
7.1.3 Jul 31, 2015: Pure Bioscience Announces Restructuring Of Its Finance Department 46
7.1.4 Jun 29, 2015: Cantel Medical Appoints David C. Hemink as President, Medivators and Michael G. Spicer as President, Americas Sales and Global Service 46
7.1.5 Jun 19, 2015: PuriCore announces Board Changes 47
7.1.6 Jun 03, 2015: Puritan Welcomes New Director of Sales, West Coast 47
7.1.7 Mar 19, 2015: Cantel Medical Announces Appointment Of Dr. Laura Forese To Its Board Of Directors 47
7.1.8 Mar 10, 2015: Maetrics announces new president 48
7.2 Financial Announcements 48
7.2.1 Dec 10, 2015: Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2015 48
7.2.2 Dec 08, 2015: Studies Demonstrate Broadening Clinical Utility of bioTheranostics’ Breast Cancer Index Molecular Test in the Extended Endocrine Therapy Setting 49
7.2.3 Dec 08, 2015: Medovex Completes Multi-Unit Streamline IV Suspension System Sale to Major Regional Hospital 51
7.2.4 Dec 07, 2015: Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium 52
7.2.5 Dec 07, 2015: Agendia’s MammaPrint and BluePrint Breast Cancer Tests to Be Highlighted at San Antonio Symposium 56
7.2.6 Dec 04, 2015: BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Model 58
7.2.7 Dec 04, 2015: Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma 59
7.2.8 Nov 10, 2015: Independent study of Cloud DX wrist cuff blood pressure monitor shown to be accurate compared to gold-standard measures by intraarterial pressure catheter in clinical setting 59
7.2.9 Nov 05, 2015: Atrion Reports Third Quarter 2015 Results 61
7.2.10 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015 61
7.2.11 Sep 29, 2015: Cantel Medical Reports Record Results For The Fourth Quarter Ended July 31, 2015 63
7.2.12 Aug 04, 2015: Atrion Reports Second Quarter 2015 Results 64
7.2.13 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 64
7.2.14 Jun 11, 2015: PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results 65
7.2.15 Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer 68
7.2.16 May 06, 2015: Atrion Reports First Quarter Results 71
7.2.17 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results 71
7.2.18 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System 73
7.2.19 Apr 16, 2015: Ethicon Receives Prestigious Award for ENSEAL G2 Articulating Tissue Sealer Innovation in Design, Sustainability Improvements 74
7.2.20 Mar 04, 2015: PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results 77
7.2.21 Feb 23, 2015: Atrion Reports Fourth Quarter and Full Year 2014 Results 79
7.2.22 Feb 20, 2015: Medigene receives positive decision on marketing authorisation for Veregen in 8 additional European countries 80
7.3 Legal And Regulatory 80
7.3.1 Jun 24, 2015: TOMI Receives EPA Registration for Its Patented BIT Technology 80
7.3.2 May 01, 2015: Hospira Statement On FDA’s Final Biosimilar Guidance Documents 81
7.3.3 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines 82
7.3.4 Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India 83
7.4 Other Significant Developments 83
7.4.1 Jan 12, 2016: New PDI Visual Resource Highlights How Proper Disinfection Can Reduce Central Line-associated Bloodstream Infections 83
7.4.2 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes 84
7.4.3 Jul 16, 2015: Delafield Solutions Joins With Pocono Medical Center to Demonstrate Effectiveness of Continuous Area Disinfection 85
7.4.4 Jun 03, 2015: Halyard Health Signs First GPO Contract as Independent Company 85
7.4.5 Mar 31, 2015: Halyard Health Signs First GPO Contracts as Independent Company: Leader in Sterilization Wrap, Facial Protection and Respiratory Health Awarded Contract with HealthTrust 85
7.4.6 Mar 03, 2015: Atrion Declares Quarterly Cash Dividend 86
7.4.7 Feb 19, 2015: Getinge Receives Double iF Design Award for the Innovative User-Interface CENTRIC and Product Design of Getinge ProSeal 86
7.5 Product News 87
7.5.1 Jan 20, 2016: rfXcel Transforms Global Compliance and Serialization With Release of Next Generation Platform 87
7.5.2 Nov 24, 2015: NuShield Provides Health Care Facilities with Germ Fighting Solution Technology 88
7.5.3 Jun 26, 2015: First Hospital Light Fixture to Kill Bacteria Safely and Continuously Becomes Commercially Available in U.S. and Canada 89
7.5.4 Jun 17, 2015: Puritan Medical Products Company updates Customers with more details about the final decision of the European Patent Office on Copan’s European Patent EP 1 608 268 B1 90
7.5.5 Jun 15, 2015: 3M/Ivera Medical & Catheter Connections Settle Patent Infringement Litigation 91
7.5.6 Apr 15, 2015: Crosstex/SPSmedical Launches SANI ProZyme Enzymatic Detergent and SANI Glut Glutaraldehyde 3% Solution 91
7.6 Strategy And Business Planning 92
7.6.1 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma 92
7.6.2 Jun 08, 2015: Massachusetts Life Sciences Center and Dana-Farber Cancer Institute announce official opening of Dana-Farber’s Molecular Cancer Imaging Facility 94
8 Appendix 96
8.1 Research Methodology 97
8.1.1 Coverage 97
8.1.2 Secondary Research 97
8.1.3 Primary Research 97
8.1.4 Company Share Analysis 98
8.1.5 Distribution Share Analysis 98
8.2 GlobalData Consulting 98
8.3 Contact Us 98
8.4 Disclaimer 99